{"id":19225,"date":"2022-01-18T08:55:23","date_gmt":"2022-01-18T07:55:23","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/e034-farmacologia-clinica\/"},"modified":"2026-04-06T10:27:35","modified_gmt":"2026-04-06T08:27:35","slug":"e034-farmacologia-clinica","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/gl\/grupo-de-investigacion\/e034-farmacologia-clinica\/","title":{"rendered":"E034 &#8211; FarmaCHUSLab"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;off&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00c1REA: <a href=\"https:\/\/www.idisantiago.es\/gl\/areas-de-investigacion\/a005-plataformas-y-metodologia\/\">PLATAFORMAS E METODOLOX\u00cdA<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.idisantiago.es\/wp-content\/uploads\/2023\/10\/FARM.inv_.Premio-NAcional23_20231011_122841_0094-scaled.jpg&#8221; title_text=&#8221;FARM.inv.Premio NAcional23_20231011_122841_0094&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Obxectivos e li\u00f1as de investigaci\u00f3n&#8221; admin_label=&#8221;Obxectivos e li\u00f1as de investigaci\u00f3n&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Obxectivos<\/h3>\n<p>No campo da investigaci\u00f3n cl\u00ednica e traslacional, os intereses do noso grupo de investigaci\u00f3n composto fundamentalmente por membros do Servizo de Farmacia da \u00c1rea Sanitaria de Santiago de Compostela con formaci\u00f3n investigadora e asistencial ori\u00e9ntanse nunha serie de aspectos fundamentais:<br \/>1.Personalizaci\u00f3n dos tratamentos farmacol\u00f3xicos: contribu\u00edr a desvelar as bases de variabilidade na resposta a f\u00e1rmacos e optimizar o resultado das terapias farmacol\u00f3xicas.<br \/>2. Desenvolvemento e caracterizaci\u00f3n gal\u00e9nica de medicamentos.<\/p>\n<h3>Li\u00f1as de investigaci\u00f3n<\/h3>\n<ul>\n<li><strong>Desenvolvemento de f\u00e1rmacos e formulaci\u00f3ns personalizadas (Galeno 4.0):<\/strong>\u00a0 Na actualidade existe un importante n\u00famero de doentes en situaci\u00f3n de baleiro terap\u00e9utico, que non dispo\u00f1en de tratamentos adaptados a s\u00faa enfermidade e\/ou condici\u00f3n espec\u00edfica. Neste punto as secci\u00f3ns de gal\u00e9nica do Servizo de Farmacia son as encargadas de dar resposta. A li\u00f1a \u201cGaleno 4.0\u201d supuxo unha reinvenci\u00f3n no desenvolvemento e optimizaci\u00f3n das formulaci\u00f3ns personalizadas adaptadas \u00f3 enfermo, sendo na actualidade o grupo, un referente nacional neste campo. T\u00f3dolos resultados obtidos nesta li\u00f1a, tiveron una traslaci\u00f3n directa a nosa pr\u00e1ctica cl\u00ednica asistencial.<\/li>\n<li><strong>Medicina personalizada farmacocin\u00e9tica:\u00a0<\/strong>Seg\u00fan o Canadian National Research Council, a Medicina Personalizada sup\u00f3n a adaptaci\u00f3n do tratamento m\u00e9dico \u00e1s \u00a0caracter\u00edsticas individuais de cada paciente. Isto sup\u00f3n a posibilidade de identificar a doentes que difiren na s\u00faa susceptibilidade a experimentar unha determinada enfermidade, na biolox\u00eda e\/ou o progn\u00f3stico de dita enfermedade, as\u00ed como na resposta ou os efectos adversos que experimentan trala administraci\u00f3n dun determinado tratamento. Esta identificaci\u00f3n real\u00edzase a trav\u00e9s da an\u00e1lise e integraci\u00f3n de datos xen\u00f3micos e t\u00e9cnicas de imaxe molecular con datos cl\u00ednicos e do contorno do paciente.<\/li>\n<li><strong>Investigaci\u00f3n cl\u00ednica independente:<\/strong>\u00a0Os ensaios cl\u00ednicos consid\u00e9ranse imprescindibles para avanzar na investigaci\u00f3n cient\u00edfica. Grazas a eles poden estar dispo\u00f1ibles novos medicamentos e tratamentos, pero a s\u00faa posta en marcha e a s\u00faa execuci\u00f3n \u00e9 custosa por iso, en m\u00e1is do 70% dos casos soen estar promovidos pola industria. Nos \u00faltimos anos a unidade coordinou varios destes ensaios, non obstante, nos \u00faltimos anos xurdiu a necesidade de promover a investigaci\u00f3n cl\u00ednica independente, que intentan resolver problemas identificados polos profesionais do sistema Nacional de Sa\u00fade que afectan aos seus pacientes. Liderar a innovaci\u00f3n na \u00e1rea de elaboraci\u00f3n de medicamentos e a aplicaci\u00f3n de t\u00e9cnicas de medicina personalizada, incl\u00fae de maneira inherente a avaliaci\u00f3n cl\u00ednica destas intervenci\u00f3ns. Actualmente a unidade coordinou a realizaci\u00f3n de ensaios cl\u00ednicos promovidos pola industria, e lidera dous ensaios cl\u00ednicos independentes no campo da infectolox\u00eda.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Equipo investigador&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 37.9876%;\"><strong>L\u00edder<\/strong><br \/>Fern\u00e1ndez Ferreiro, Anxo<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Col\u00edder\u00a0<\/strong><br \/>Mondelo Garc\u00eda, Cristina<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Membros<\/strong><br \/>Almu\u00ed\u00f1a Varela, Pablo<br \/>\u00c1lvarez Barrios, Ana<br \/>Band\u00edn Vilar, Enrique Jos\u00e9<br \/>Bern\u00e1rdez Ferr\u00e1n, Beatriz<br \/>Busto Iglesias, Manuel<br \/>Cajade Pascual, Francisco<br \/>Carpintero Maggiori, Charo Andrea<br \/>Castro Balado, Ana<br \/>Castro Fern\u00e1ndez, Diana Carolina<br \/>Cuartero Mart\u00ednez, Andrea<br \/>Dom\u00ednguez Santana, Carmen Mar\u00eda<br \/>Dur\u00e1n Pi\u00f1eiro, Goretti<br \/>Feij\u00f3o Vilanova, Pablo<br \/>Feitosa Medeiros, Ana Carolina<br \/>Fraga Codesido, J\u00e9ssica<br \/>Garc\u00eda Quintanilla, Laura<br \/>Gil Mart\u00ednez, Mar\u00eda<\/p>\n<\/td>\n<td style=\"width: 62.0124%;\">Gir\u00e1ldez Montero, Jos\u00e9 Mar\u00eda<br \/>Gonz\u00e1lez Barcia, Miguel<br \/>Gonz\u00e1lez L\u00f3pez, Jaime<br \/>Hermelo Vidal, Gonzalo<br \/>Mart\u00ednez Guiti\u00e1n, Marta<br \/>Rodr\u00edguez Fern\u00e1ndez, Carmen Ant\u00eda<br \/>Rodr\u00edguez Mart\u00ednez, Lorena<br \/>Toja Camba, Francisco Jos\u00e9<br \/>Varela Rey, Iria<br \/>Vidal Millares, Mar\u00eda<br \/>Zarra Ferro, Irene<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Persoal Colaborador Externo<\/strong><br \/>Lamas D\u00edaz, Mar\u00eda Jes\u00fas<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Proxectos&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; locked=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<strong>Determinaci\u00f3n prote\u00f3mica del efecto de la cisteamina a nivel molecular en c\u00e9lulas de pacientes con cistinosis nefrop\u00e1tica<\/strong><br \/>C\u00f3digo del proyecto: PROTEOCYST<br \/>Entidad financiadora: Colegio de farmac\u00e9uticos de Sevilla<br \/>Duraci\u00f3n: 2023<br \/>Cuant\u00eda: 6 000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Jes\u00fas Mateos Mart\u00edn<br \/><\/p>\n<p><strong>Farmacocin\u00e9tica, prote\u00f3mica e imagen molecular en la individualizaci\u00f3n terap\u00e9utica de linezolid en infecciones osteoarticulares<\/strong><br \/>C\u00f3digo del proyecto: PI22\/00038<br \/>Entidad financiadora: Instituto de Salud Carlos III<br \/>Duraci\u00f3n: 2023-2025<br \/>Cuant\u00eda: 48 400 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Cristina Mondelo Garc\u00eda<br \/><\/p>\n<p><strong>La investigaci\u00f3n traslacional en la optimizaci\u00f3n terap\u00e9utica de la queratoconjuntivitis vernal con tacrolimus oft\u00e1lmico \u201cOFTAC-VER\u201d<\/strong><br \/>C\u00f3digo del proyecto: FEFH2022<br \/>Entidad financiadora: Fundaci\u00f3n Espa\u00f1ola de Farmacia Hospitalaria<br \/>Duraci\u00f3n: 2022-2023<br \/>Cuant\u00eda: 14 500 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Ana Castro Balado<br \/><\/p>\n<p><strong>STOP CISTINOSIS. Nuevas DianaS moleculares identificadas por proTeOmica y rePosicionamiento de f\u00e1rmacos en el tratamiento de la cistinosis Infantil<\/strong><br \/>C\u00f3digo del proyecto: MUTUA22<br \/>Entidad financiadora: Fundaci\u00f3n Mutua Madrile\u00f1a<br \/>Duraci\u00f3n: 2022-2025<br \/>Cuant\u00eda: 120 750 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publicaci\u00f3ns&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Varela Rey I, Band\u00edn Vilar EJ, Cant\u00f3n Blanco A, Martinon Torres N, Amoedo Fari\u00f1a B, Gayoso Gonz\u00e1lez D, Barrientos Lema I, de Moura Ramos JJ, Zarra Ferro I, Gonz\u00e1lez Barcia M, Mondelo Garc\u00eda C, Mart\u00ednez Olmos M\u00c1, Fern\u00e1ndez Ferreiro A. <strong>NEmecum: digital tool to help the prescription and dispensation of enteral nutrition and infant nutrition formulas. Development, diffusion and analysis of results and usage data. <\/strong><em>Nutr Hosp.<\/em> 2023 Aug 30. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37705457\/\">doi: 10.20960\/nh.04720<\/a><\/strong><\/span>. Online ahead of print. PMID: 37705457<\/li>\n<li>Rodr\u00edguez-Mart\u00ednez L, Castro-Balado A, Hermelo-Vidal G, Band\u00edn-Vilar E, Varela-Rey I, Toja-Camba FJ, Rodr\u00edguez-Jato T, Novo-Veleiro I, Varela-Garc\u00eda PM, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Mateos J, Fern\u00e1ndez-Ferreiro A. <strong>Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy.<\/strong> <em>Pharmaceutics<\/em>. 2023 Aug 8;15(8):2099. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37631313\/#new_tab\">doi: 10.3390\/pharmaceutics15082099<\/a><\/strong><\/span>. PMID:\u00a037631313<\/li>\n<li>Busto-Iglesias M, Rodr\u00edguez-Mart\u00ednez L, Rodr\u00edguez-Fern\u00e1ndez CA, Gonz\u00e1lez-L\u00f3pez J, Gonz\u00e1lez-Barcia M, de Domingo B, Rodr\u00edguez-Rodr\u00edguez L, Fern\u00e1ndez-Ferreiro A, Mondelo-Garc\u00eda C. <strong>Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.<\/strong> <em>Pharmaceutics<\/em>. 2023 Feb 25;15(3):766. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36986627\/#new_tab\">doi: 10.3390\/pharmaceutics15030766<\/a><\/strong><\/span>. PMID: 36986627<\/li>\n<li>Castro-Balado A, Novo-Veleiro I, V\u00e1zquez-Agra N, Barbeito-Casti\u00f1eiras G, Estany-Gestal A, Trastoy-Pena R, Gonz\u00e1lez-Barcia M, Zarra-Ferro I, Del R\u00edo-Garma MC, Crespo-Diz C, Delgado-S\u00e1nchez O, Otero-Espinar FJ, Mondelo-Garc\u00eda C, Pose-Reino A, Fern\u00e1ndez-Ferreiro A. <strong>Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial. <\/strong><em>Pharmaceutics<\/em>. 2023 Feb 16;15(2):667. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36839987\/#new_tab\">doi: 10.3390\/pharmaceutics15020667<\/a><\/strong><\/span>. PMID: 36839987<\/li>\n<li>Varela-Rey I, de la Iglesia D, San Bruno-Ruz A, Mejuto-Fern\u00e1ndez R, Monteser\u00edn-Ron L, L\u00f3pez-Diaz J, Garc\u00eda-Salom P, Gonz\u00e1lez-Cantalapiedra A, Manuel Brea J, Pi\u00f1a-M\u00e1rquez R, D\u00edaz-Tom\u00e9 V, Gonz\u00e1lez-Barcia M, Zarra-Ferro I, Mondelo-Garc\u00eda C, Dominguez-Mu\u00f1oz E, Otero-Espinar F, Fern\u00e1ndez-Ferreiro A. <strong>Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps.<\/strong> <em>Int J Pharm.<\/em> 2023 Mar 25;635:122706. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36803925\/\"><span style=\"color: #808000;\"><strong>doi: 10.1016\/j.ijpharm.2023.122706<\/strong><\/span><\/a>. PMID: 36803925<\/li>\n<li>Castro-Balado A, Band\u00edn-Vilar E, Cuartero-Mart\u00ednez A, Garc\u00eda-Quintanilla L, Hermelo-Vidal G, Garc\u00eda-Otero X, Rodr\u00edguez-Mart\u00ednez L, Mateos J, Hern\u00e1ndez-Blanco M, Aguiar P, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Otero-Espinar FJ, Fern\u00e1ndez-Ferreiro A. <strong>Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.<\/strong> <em>Pharmaceutics<\/em>. 2022 Oct 15;14(10):2194. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36297629\/\">doi: 10.3390\/pharmaceutics14102194<\/a><\/strong><\/span>. PMID: 36297629<\/li>\n<li>Band\u00edn-Vilar E, Garc\u00eda-Quintanilla L, Castro-Balado A, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Campos-Toimil M, Mangas-Sanjuan V, Mondelo-Garc\u00eda C, Fern\u00e1ndez-Ferreiro A. <strong>A Review of Population Pharmacokinetic Analyses of Linezolid.<\/strong> <em>Clin Pharmacokinet.<\/em> 2022 Jun;61(6):789-817. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9192929\/\">doi: 10.1007\/s40262-022-01125-2<\/a><\/strong><\/span>. Epub 2022 Jun 14. PMID: 35699914<\/li>\n<li>Garc\u00eda-Quintanilla L, Rodr\u00edguez-Mart\u00ednez L, Band\u00edn-Vilar E, Gil-Mart\u00ednez M, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Fern\u00e1ndez-Ferreiro A, Mateos J. <strong>Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review.<\/strong> <em>Int J Mol Sci<\/em>. 2022 Nov 25;23(23):14759. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36499086\/\"><span style=\"color: #808000;\"><strong>doi: 10.3390\/ijms232314759.<\/strong><\/span><\/a> PMID: 36499086<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Web do grupo&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"QnBgNyTj44\"><p><a href=\"https:\/\/mibiopharm.com\/unidad-farmacia-hospitalaria\/\">I+i en Farmacia Hospitalaria<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u00abI+i en Farmacia Hospitalaria\u00bb \u2014 Farmachus Lab\" src=\"https:\/\/mibiopharm.com\/unidad-farmacia-hospitalaria\/embed\/#?secret=WTtwRmZ1Q3#?secret=QnBgNyTj44\" data-secret=\"QnBgNyTj44\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Investigador l\u00edder<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-44188\" class=\"sp-team-pro sptp-section sptp-modal pagination_number sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"44187\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar  sptp-popup-trigger \"  href=javascript:void(0) target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"44187\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" src=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" alt=\"Anxo Fern\u00e1ndez Ferreiro\" width=\"600\" height=\"450\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tAnxo Fern\u00e1ndez Ferreiro\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-profession\">\n\t\t\t<h4>Investigador l\u00edder del grupo E034 \u2013 FarmaCHUSLab<\/h4>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>Anxo.Fernandez.Ferreiro@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Investigadora col\u00edder<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-40915\" class=\"sp-team-pro sptp-section sptp-modal pagination_number sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"44040\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar  sptp-popup-trigger \"  href=javascript:void(0) target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"44040\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" src=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" alt=\"Cristina Mondelo Garc\u00eda\" width=\"600\" height=\"450\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tCristina Mondelo Garc\u00eda\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-profession\">\n\t\t\t<h4>Investigadora col\u00edder del grupo E034 - FarmaCHUSLab<\/h4>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>cristina.mondelo.garcia@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1REA: PLATAFORMAS E METODOLOX\u00cdAObxectivos No campo da investigaci\u00f3n cl\u00ednica e traslacional, os intereses do noso grupo de investigaci\u00f3n composto fundamentalmente por membros do Servizo de Farmacia da \u00c1rea Sanitaria de [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":30653,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[515],"project_tag":[],"class_list":["post-19225","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-plataformas-y-metodologia-gl"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/19225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/comments?post=19225"}],"version-history":[{"count":40,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/19225\/revisions"}],"predecessor-version":[{"id":45915,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/19225\/revisions\/45915"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media\/30653"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media?parent=19225"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_category?post=19225"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_tag?post=19225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}